GS
IDXX icon

GTS Securities’s Idexx Laboratories IDXX Stock Holding History

GTS Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-640
Closed -$360K – 1602
2026
Q1 		$360K Sell
640
-573
-47% -$367K 0.01% 985
2025
Q4 		$821K Sell
1,213
-614
-34% -$418K 0.03% 524
2025
Q3 		$1.17M Buy
+1,827
New +$1.11M 0.04% 348
2025
Q2 		– Sell
-837
Closed -$351K – 1414
2025
Q1 		$351K Buy
837
+229
+38% +$99.4K 0.02% 873
2024
Q4 		$251K Sell
608
-470
-44% -$206K 0.01% 986
2024
Q3 		$545K Buy
1,078
+651
+152% +$316K ﹤0.01% 2741
2024
Q2 		$208K Buy
+427
New +$214K ﹤0.01% 3418
2024
Q1 		– Sell
-626
Closed -$347K – 4127
2023
Q4 		$347K Sell
626
-193
-24% -$90.6K ﹤0.01% 3088
2023
Q3 		$358K Buy
+819
New +$408K ﹤0.01% 2910

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GTS Securities's IDXX Position: Q2 2026 in Review

GTS Securities sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 640 shares — an estimated $360K sold.

GTS Securities first reported a position in IDXX in Q3 2023 and held it in 9 quarters. The position peaked at $1.17M in Q3 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • GTS Securities reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 640 Idexx Laboratories shares in Q2 2026, an estimated $360K.
  • GTS Securities first reported a position in Idexx Laboratories in Q3 2023 and held it in 9 quarters.
  • GTS Securities's Idexx Laboratories position peaked at $1.17M in Q3 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.